tangeretin has been researched along with Breast Neoplasms in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Bönisch, H; Haenisch, B; Mayer, R; Müller, CE; Müller, H; Pajeva, IK; Pick, A; Weigt, M; Wiese, M | 1 |
| Abdin, SM; Mdkhana, B; Omar, HA; Zaher, DM | 1 |
| Androutsopoulos, VP; Arroo, RR; Surichan, S; Tsatsakis, AM | 1 |
| Canivenc-Lavier, MC; Chagnon, MC; Lhuguenot, JC; Picard, K; Stroheker, T | 1 |
| Boterberg, T; Bracke, ME; Coopman, P; De Bondt, B; Depypere, HT; Foré, F; Leclercq, G; Parmar, VS; Sharma, SK; Van Slambrouck, S; Vanhoecke, BW | 1 |
| Ferguson, PJ; Koropatnick, J; Morley, KL | 1 |
| Bracke, ME; Mareel, MM; Van Roy, FM | 1 |
| Boterberg, T; Bracke, ME; Depypere, HT; Mareel, MM; Nuytinck, M; Serreyn, R; Van Marck, VL; Vanluchene, E; Vennekens, KM | 1 |
| Boterberg, T; Brack, ME; Depypere, HT; Leclercq, G; Mareel, MM; Stove, C | 1 |
2 review(s) available for tangeretin and Breast Neoplasms
| Article | Year |
|---|---|
The E-cadherin/catenin complex in invasion and metastasis.
Topics: Adenocarcinoma; alpha Catenin; Animals; beta Catenin; Breast Neoplasms; Cadherins; Cell Polarity; Cytoskeletal Proteins; Cytoskeleton; Desmoplakins; Dogs; Epithelium; Fetal Proteins; Flavones; Flavonoids; Gene Expression Regulation, Neoplastic; Humans; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Macromolecular Substances; Multigene Family; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Protein Conformation; Receptor, IGF Type 1; Structure-Activity Relationship; Tamoxifen; Trans-Activators; Tretinoin; Tumor Cells, Cultured | 1996 |
The citrus methoxyflavone tangeretin affects human cell-cell interactions.
Topics: Animals; beta Catenin; Breast Neoplasms; Cadherins; Carcinoma; Cell Adhesion; Citrus; Contraindications; Cytoskeletal Proteins; Drug Interactions; Estrogen Receptor Modulators; Female; Flavones; Flavonoids; Humans; Immunosuppressive Agents; Killer Cells, Natural; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Proteins; Tamoxifen; Trans-Activators; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2002 |
7 other study(ies) available for tangeretin and Breast Neoplasms
| Article | Year |
|---|---|
Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Flavonoids; Humans; Hydrogen Bonding; Models, Molecular; Neoplasm Proteins; Quantitative Structure-Activity Relationship | 2011 |
Tangeretin boosts the anticancer activity of metformin in breast cancer cells via curbing the energy production.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Survival; Drug Resistance, Neoplasm; Female; Flavones; Humans; MCF-7 Cells; Metformin | 2021 |
Tangeretin inhibits the proliferation of human breast cancer cells via CYP1A1/CYP1B1 enzyme induction and CYP1A1/CYP1B1-mediated metabolism to the product 4' hydroxy tangeretin.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1B1; Enzyme Induction; Female; Flavones; G1 Phase Cell Cycle Checkpoints; Humans | 2018 |
Steroid activities comparison of natural and food wrap compounds in human breast cancer cell lines.
Topics: Anticarcinogenic Agents; Antineoplastic Agents; Apigenin; Benzhydryl Compounds; Breast Neoplasms; Carcinogens; Dose-Response Relationship, Drug; Endocrine System; Epoxy Compounds; Estrogens, Non-Steroidal; Female; Flavones; Flavonoids; Food Packaging; Genistein; Humans; Kaempferols; Phenols; Receptors, Androgen; Receptors, Estrogen; Tumor Cells, Cultured | 2004 |
Tangeretin inhibits extracellular-signal-regulated kinase (ERK) phosphorylation.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Estradiol; Extracellular Signal-Regulated MAP Kinases; Female; Flavones; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Molecular Structure; Phosphorylation; Protein Kinase Inhibitors; Signal Transduction | 2005 |
Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Dose-Response Relationship, Drug; Female; Flavones; G1 Phase; HT29 Cells; Humans; Molecular Structure; Time Factors | 2007 |
Influence of tangeretin on tamoxifen's therapeutic benefit in mammary cancer.
Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Drug Synergism; Female; Flavones; Flavonoids; Gene Expression Regulation, Neoplastic; Killer Cells, Natural; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Plant Extracts; Tamoxifen; Tumor Cells, Cultured | 1999 |